Yakira Capital Management’s Checkpoint Therapeutics CKPT Stock Holding History

Yakira Capital Management’s Portfolio CKPT Stock Details CKPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-122,200	Closed	-$494K	–	207
2025 Q1	$494K	Buy	+122,200	New	+$407K	0.19%	87

Yakira Capital Management's CKPT Position: Q2 2025 in Review

Yakira Capital Management sold out of Checkpoint Therapeutics (CKPT) in Q2 2025, closing a stake of 122,200 shares — an estimated $494K sold.

Yakira Capital Management first reported a position in CKPT in Q1 2025 and held it in 1 quarter. The position peaked at $494K in Q1 2025. 0 funds tracked by Wall St. Rank hold CKPT as of Q2 2025.

Yakira Capital Management reported no remaining Checkpoint Therapeutics position as of Q2 2025 after selling out during the quarter.
Yakira Capital Management sold 122,200 Checkpoint Therapeutics shares in Q2 2025, an estimated $494K.
Yakira Capital Management first reported a position in Checkpoint Therapeutics in Q1 2025 and held it in 1 quarter.
Yakira Capital Management's Checkpoint Therapeutics position peaked at $494K in Q1 2025.
0 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q2 2025.

Based on Yakira Capital Management's 13F filing for Q2 2025, filed 13 Aug 2025.